High Rate of Virological Response to Peginterferon α-2a–Ribavirin Among Non-Cirrhotic Iranian Hemophilia Patients With Chronic Hepatitis C

BACKGROUND: Hepatitis C is a major reason of morbidity and mortality among hemophilia patients. Although combination therapy with peginterferon (peg-INF) and ribavirin is considered as standard treatment for chronic hepatitis C (CHC), but more evidence of the efficacy and safety is needed. OBJECTIVE...

Descripción completa

Detalles Bibliográficos
Autores principales: Alavi Moghaddam, Mostafa, Zali, Mohammad Reza, Aalaei Andabili, Seyed Hossein, Derakhshan, Faramarz, Miri, Seyed Mohammad, Alavian, Seyed Moayed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470839/
https://www.ncbi.nlm.nih.gov/pubmed/23105981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470839/
https://www.ncbi.nlm.nih.gov/pubmed/23105981

Ejemplares similares